Table 3.
Impact of different induction therapies on CR/CRi rate.
Group | IA | DA | CAG | P value |
---|---|---|---|---|
AML with BMF, n (%) | 26 (57.78%) | 14 (53.85%) | 10 (41.67%) | 0.446 |
AML without BMF, n (%) | 12 (85.71%) | 10 (62.50%) | 21 (75.00%) | 0.359 |
AML, acute myeloid leukemia; BMF, bone marrow fibrosis; CR, complete remission; CRi, morphologic complete remission with incomplete blood count recovery.